Prediction and Intervention in Developmental Dyslexia (LEXI)

August 13, 2014 updated by: University of Zurich

Neuronal Markers of Grapheme-phoneme Training Response for Prediction of Successful Reading Acquisition in Children at Familial Risk for Developmental Dyslexia

The long-term goal of this study is to improve prediction of poor reading outcome at preschool age by using a combination of behavioural and neuroimaging measures and to evaluate a specific computerized training program to support children with problems during reading acquisition.

Study Overview

Status

Unknown

Study Type

Interventional

Enrollment (Anticipated)

110

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Zurich, Switzerland, 8032
        • Recruiting
        • University Clinics for Child and Adolescent Psychiatry, University of Zurich
        • Principal Investigator:
          • Silvia Brem, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 9 years (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria for all groups:

  • Healthy, native (CH-) German speaking subjects, with an estimated non-verbal intelligence quotient (IQ) >=80, without neurological and/or psychiatric disorder (except for attention deficit hyperactivity disorder, specific learning disorders, developmental language impairments)
  • Additional criteria for subgroups:
  • Recruitment of preschoolers (aged 5.5-7.5 years):
  • Healthy children with increased risk for developmental dyslexia in their second year at kindergarten
  • Recruitment of children in first grade (aged 6.5-8.5years):
  • Children showing impairments in learning to read (first/second grade).
  • Adults (aged 20-40 years):
  • Healthy, normal reading

Exclusion Criteria for all groups:

  • MRI contraindications
  • No history of premature delivery and/or maternal reports of severe prenatal, perinatal or postnatal complications.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Computerized reading training first
Cross-over design: group first receives the intervention
Experimental: Waiting Control First
Cross-over design: group first serves as waiting control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in reading and spelling performance
Time Frame: Participants will be tested at three times for the duration of the cross-sectional intervention, an expected average of 8 months
Performance in normed reading and/or spelling (standardized tests) as a result of reading acquisition and training
Participants will be tested at three times for the duration of the cross-sectional intervention, an expected average of 8 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Developmental and training induced changes in functional brain activation and brain structure
Time Frame: Participants will be tested after an expected average of 8, 12 and 16 months
Changes in activation/structure of core language network regions assessed by EEG and MRI during development, learning and training
Participants will be tested after an expected average of 8, 12 and 16 months
Accuracy of prediction on reading performance outcome
Time Frame: Participants will be tested at T1 and on average 8 months later

Accuracy of prediction on reading performance (standardized tests) using behavioural and/or neuroimaging measures.

Neuroimaging measures: EEG and MRI (functional activation, structural measures from white and/or grey matter, temporal information from event-related potential and/or frequency analyses)

Participants will be tested at T1 and on average 8 months later

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Silvia Brem, PhD, University Clinics for Child and Adolescent Psychiatry, University of Zurich

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2013

Primary Completion (Anticipated)

July 1, 2018

Study Completion (Anticipated)

July 1, 2018

Study Registration Dates

First Submitted

August 8, 2014

First Submitted That Met QC Criteria

August 13, 2014

First Posted (Estimate)

August 15, 2014

Study Record Updates

Last Update Posted (Estimate)

August 15, 2014

Last Update Submitted That Met QC Criteria

August 13, 2014

Last Verified

August 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Developmental Dyslexia

Clinical Trials on Computerized reading training

3
Subscribe